Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-794-4999
Dr. Puduvalli is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Expertise
- Neuro-oncology, Glioblastoma, Astrocytoma, Oligodendroglioma, Gliomas, Primary brain tumors, Metastatic brain tumors, Cancer Neurology
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 1996 - 1998
University of Texas Health Science Center at HoustonResidency, Neurology, 1993 - 1996
Texas Tech University (Amarillo)Internship, Internal Medicine, 1992 - 1993
Bangalore Medical CollegeClass of 1983
Certifications & Licensure
AZ State Medical License 2023 - 2028
MS State Medical License 2023 - 2027
OK State Medical License 2023 - 2027
TN State Medical License 2023 - 2027
AL State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
American Board of Psychiatry and Neurology Neurology- Join now to see all
Awards, Honors, & Recognition
- Beau Biden Endowed Chair in Brain Cancer Research UT MD Anderson Cancer Center, 2021
- Top Doctors in Columbus Columbus Monthly
- America's Top Doctors for Cancer Castle Connolly
Clinical Trials
- Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) Start of enrollment: 2007 Nov 28
- Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I Start of enrollment: 2008 Apr 29
- Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- Cystic glioblastoma is associated with alterations of KDR and the Rb pathway: a single-center retrospective analysis.Johannes Werner, Sahar Alizada, Cheuk Hong Leung, Heather Lin, Ahmed Msherghi
Acta Neuropathologica Communications. 2026-06-14 - Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma.JongHoon Ha, Yifan Wang, Yifan Ma, Annette Wu, Shiyan Dong
Nature Communications. 2026-03-09 - CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.Shuodan Zhang, Byram H Ozer, Antonio Omuro, Ying Yuan, Tito Mendoza
Neuro-Oncology Advances. 2026-03-09
Grant Support
- Characterization of Onalespib, A novel long acting Hsp90 inhibitor, as a chemo and radiosensitizer in Adults with Newly Diagnosed GlioblastomaNational Cancer institute2019–2025
- Patient Oriented Research Program In Neuro-OncologyNational Cancer Institute2012
- Efficacy And Toxicity Of Trail Against GliomasNational Cancer Institute2006–2010
- Correlative Trial Of Fenretinide Against GlioblastomasNational Cancer Institute2002–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
